S100 and impact of ECT on depression and cognition

Journal of ECT

Volumn 22, Issue 3, 2006, Pages 206-212

  Arts, Baer ^a   Peters, Maarten ^a   Ponds, Rudolf ^a   Honig, Adriaan ^c   Menheere, Paul ^d   Van Os, Jim ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cognition; Depression; ECT; Prospective; S100

Indexed keywords

PROTEIN S 100; PROTEIN S100B;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PROTEIN BLOOD LEVEL; SYMPTOM CHECKLIST 90; TREATMENT OUTCOME; WORKING MEMORY;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 33748618988     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/01.yct.0000235925.37494.2c     Document Type: Article

References (60)

1. Bauer M. Review: electroconvulsive therapy may be an effective short term treatment for people with depression. Evid Based Ment Health. 2003;6(3):83.
2. Kho KH, van Vreeswijk MF, Simpson S, et al. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT. 2003;19(3):139-147.
3. Pagnin D, de Queiroz V, Pini S, et al. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004;20(1):13-20.
4. Lisanby SH, Maddox JH, Prudic J, et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry. 2000;57(6):581-590.
5. Sackeim HA. Memory and ECT: from polarization to reconciliation. J ECT. 2000;16(2):87-96.
6. Calev A, Gaudino EA, Squires NK, et al. ECT and non-memory cognition: a review. Br J Clin Psychol. 1995;34(Pt 4):505-515.
7. Devanand DP, Dwork AJ, Hutchinson ER, et al. Does ECT alter brain structure? Am J Psychiatry. 1994;151:957-970.
8. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33(7):637-668.
9. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60(6):540-551.
10. Heizmann CW. Ca2+-binding S100 proteins in the central nervous system. Neurochem Res. 1999;24(9):1097-1100.
11. Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci. 2003;21(3-4):97-108.
12. Whitaker-Azmitia PM, Azmitia EC. Astroglial 5-HT1a receptors and S-100 in development and plasticity. Perspect Dev Neurobiol. 1994;2(3):233-238.
13. Gerlai R, Roder J. Spatial and nonspatial learning in mice: effects of S100 beta overexpression and age. Neurobiol Learn Mem. 1996;66(2):143-154.
14. Whitaker-Azmitia PM, Wingate M, Borella A, et al. Transgenic mice overexpressing the neurotrophic factor S-100 show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 1997;776:51-60.
15. Hu J, Van Eldik LJ. S100 beta induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim Biophys Acta. 1996;1313(3):239-245.
16. Linstedt U, Meyer O, Kropp P, et al. Serum concentration of S-100 protein in assessment of cognitive dysfunction after general anesthesia in different types of surgery. Acta Anaesthesiol Scand. 2002;46(4):384-289.
17. Rasmussen LS, Christiansen M, Rasmussen H, et al. Do blood concentrations of neurone specific enolase and S-100 beta protein reflect cognitive dysfunction after abdominal surgery? ISPOCD Group. Br J Anaesth. 2000;84(2):242-244.
18. Basile AM, Fusi C, Conti AA, et al. S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol. 2001;45(3):151-159.
19. Jonsson H. S100B and cardiac surgery: possibilities and limitations. Restor Neurol Neurosci. 2003;21(3-4):151-157.
20. Kilminster S, Treasure T, McMillan T, et al. Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke. 1999;30(9):1869-1874.
21. Snyder-Ramos SA, Gruhlke T, Bauer H, et al. Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia. 2004;59(4):344-349.
22. Svenmarker S, Sandstrom E, Karlsson T, et al. Is there an association between release of protein S100B during cardiopulmonary bypass and memory disturbances? Scand Cardiovasc J. 2002;36(2):117-122.
23. Connolly ES, Winfree CJ, Rampersad A, et al. Serum S100 protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery. 2001;49(5):1076-1082.
24. Buttner T, Weyers S, Postert T, et al. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke. 1997;28(10):1961-1965.
25. Rothoerl RD, Woertgen C, Holzschuh M, et al. S-100 serum levels after minor and major head injury. J Trauma. 1998;45(4):765-767.
26. Savola O, Pyhtinen J, Leino TK, et al. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma. 2004;56(6):1229-1234. discussion 1234.
27. Waterloo K, Ingebrigtsen T, Romner B. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir (Wien). 1997;139(1):26-31. discussion 31-32.
28. Jankovic BD, Djordjijevic D. Differential appearance of autoantibodies to human brain S100 protein, neuron specific enolase and myelin basic protein in psychiatric patients. Int J Neurosci. 1991;60:119-127.
29. Machado-Vieira R, Lara DR, Portela LV, et al. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol. 2002;12(3):269-272.
30. Rothermundt M, Missler U, Arolt V, et al. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry. 2001b;6(4):445-449.
31. Wiesmann M, Wandinger KP, Missler U, et al. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry. 1999;45(11):1508- 1511.
32. Grabe HJ, Ahrens N, Rose H-J, et al. Neurotrophic factor S100 beta in major depression. Neuropsychobiology. 2001;44:88-90.
33. Rothermundt M, Arolt V, Wiesmann M, et al. S-100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord. 2001a;66(1):89-93.
34. Zachrisson OC, Balldin J, Ekman R, et al. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res. 2000;96(2):157-165.
35. Berrouschot J, Rolle K, Kuhn HJ, et al. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. J Neurol Sci. 1997;150(2):173-176.
36. Buttner T, Lack B, Jager M, et al. Serum levels of neuron-specific enolase and S-100 protein after single tonic-clonic seizures. J Neurol. 1999;246(6):459-461.
37. Palmio J, Peltola J, Vuorinen P, et al. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. J Neurol Sci. 2001;183(1):27-31.
38. Agelink MW, Andrich J, Postert T, et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry. 2001;71(3):394-396.
39. Jonsson H, Johnsson P, Hoglund P, et al. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth. 2000;14(6):698-701.
40. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
41. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol. 1985;112(2):201-210.
42. Houx PJ, Vreeling FW, Jolles J. Rigorous health screening reduces age effect on memory scanning task. Brain Cogn. 1991;15(2):246-260.
43. Lezak MD. Neuropsychological assessment. New York, NY: Oxford University Press, 1995.
44. Broadbent DE, Cooper PF, FitzGerald P, et al. The Cognitive Failure Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21:1-16.
45. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull. 1973;9(1):13-28.
46. Rummel RJ. Applied Factor Analysis. Evanston, IL: Northwestern University Press, 1970.
47. Krabbendam L, Marcelis M, Delespaul P, et al. Single or multiple familial cognitive risk factors in schizophrenia? Am J Med Genet. 2001;105(2):183-188.
48. StataCorp. STATA Statistical Software. College Station, 2002.
49. Sheng JG, Mrak RE, Rovnaghi CR, et al. Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging. 1996;17(3):359-363.
50. Arolt V, Peters M, Erfurth A, et al. S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol. 2003;13(4):235-239.
51. de Kruijk JR, Leffers P, Menheere PP, et al. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurol Scand. 2001;103(3):175-179.
52. Missler U, Wiesmann M. Measurement of S-100 protein in human blood and cerebrospinal fluid: analytical method and preliminary clinical results. Eur J Clin Chem Clin Biochem. 1995;33(10):743-748.
53. Schroeter ML, Abdul-Khaliq H, Diefenbacher A, et al. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport. 2002;13(13):1675-1678.
54. Margis R, Zanatto VC, Tramontina F, et al. Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Res. 2004;1028:213-218.
55. Scaccianoce S, Del Bianco P, Pannitteri G, et al. Relationship between stress and circulating levels of S100B protein. Brain Res. 2004;1004:208-211.
56. Kleindienst A, Harvey HB, Rice AC, et al. Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat. J Neurotrauma. 2004;21(5):541-547.
57. Hellsten J, Wennstrom M, Bengzon J, et al. Electroconvulsive seizures induce endothelial cell proliferation in adult rat hippocampus. Biol Psychiatry. 2004;55(4):420-427.
58. Madhav TR, Pei Q, Grahame-Smith DG, et al. Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus. Neuroscience. 2000;97(4):677-683.
59. Dietrich DE, Hauser U, Peters M, et al. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression. Neurosci Lett. 2004;354(1):69-73.
60. Rabbitt P, Abson V. "Lost and found": some logical and methodological limitations of self-report questionnaires as tools to study cognitive ageing. Br J Psychol. 1990;81(Pt 1):1-16.